HUB Investment Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.75M Buy
197,054
+42,703
+28% +$1.12M 0.09% 182
2026
Q1
$4.33M Buy
154,351
+7,639
+5% +$203K 0.1% 171
2025
Q4
$3.65M Buy
146,712
+19,542
+15% +$493K 0.09% 161
2025
Q3
$3.24M Buy
127,170
+24,843
+24% +$613K 0.11% 157
2025
Q2
$2.48M Buy
102,327
+31,896
+45% +$744K 0.08% 170
2025
Q1
$1.78M Sell
70,431
-245
-0.3% -$6.41K 0.07% 174
2024
Q4
$1.88M Sell
70,676
-3,047
-4% -$82.6K 0.08% 159
2024
Q3
$2.13M Sell
73,723
-2,902
-4% -$84.7K 0.09% 148
2024
Q2
$2.14M Buy
76,625
+7,025
+10% +$193K 0.08% 148
2024
Q1
$1.93M Buy
69,600
+26,890
+63% +$746K 0.11% 148
2023
Q4
$1.23M Buy
42,710
+26,245
+159% +$793K 0.08% 158
2023
Q3
$546K Buy
16,465
+7,054
+75% +$249K 0.08% 130
2023
Q2
$345K Sell
9,411
-1,723
-15% -$67.1K 0.06% 174
2023
Q1
$454K Buy
+11,134
New +$481K 0.09% 131
2022
Q4
Sell
-11,125
Closed -$487K 160
2022
Q3
$487K Buy
11,125
+4,856
+77% +$236K 0.15% 104
2022
Q2
$329K Buy
6,269
+56
+0.9% +$2.85K 0.1% 124
2022
Q1
$322K Sell
6,213
-1,999
-24% -$104K 0.08% 138
2021
Q4
$485K Sell
8,212
-9,099
-53% -$451K 0.11% 122
2021
Q3
$745K Sell
17,311
-2,484
-13% -$110K 0.18% 112
2021
Q2
$775K Sell
19,795
-1,792
-8% -$69.7K 0.21% 102
2021
Q1
$782K Buy
21,587
+4,875
+29% +$173K 0.23% 101
2020
Q4
$613K Buy
+16,712
New +$613K 0.28% 83

Other funds holding PFE

HUB Investment Partners's PFE Position: Q2 2026 in Review

HUB Investment Partners increased its Pfizer (PFE) stake by 28% in Q2 2026, buying an estimated $1.12M and bringing the position to 197,054 shares worth $4.75M. The position accounts for 0.09% of the portfolio, ranked #182.

HUB Investment Partners first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • HUB Investment Partners held 197,054 shares of Pfizer worth $4.75M as of Q2 2026.
  • HUB Investment Partners bought 42,703 Pfizer shares in Q2 2026, an estimated $1.12M.
  • Pfizer made up 0.09% of HUB Investment Partners's portfolio in Q2 2026, its #182 holding.
  • HUB Investment Partners first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on HUB Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.